Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discovery

Area of Science:

• Oncology
• Pharmacology
• Biochemistry

Background:

• Multidrug resistance (MDR) significantly limits the efficacy of chemotherapeutic drugs in cancer treatment.
• ATP-binding cassette (ABC) transporters are a primary mechanism mediating MDR by effluxing anticancer agents from tumor cells.
• Diminished drug responsiveness in cancer cells poses a major obstacle to achieving therapeutic success.

Purpose of the Study:

• To review current strategies for overcoming MDR in cancer therapy.
• To discuss the features and mechanisms of ABC transporters involved in MDR.
• To explore novel approaches and potential therapeutic agents for reversing MDR.

Main Methods:

• Review of conventional synthetic and natural inhibitors of ABC transporters.
• Exploration of novel strategies including RNA-based therapies, monoclonal antibodies, and nanobiotechnology.
• Discussion of structure-based rational design of inhibitors and the potential of herbal products.

Main Results:

• Conventional inhibitors and novel approaches offer potential avenues to combat MDR.
• Understanding ABC transporter structure facilitates the rational design of effective MDR inhibitors.
• Certain herbal compounds show promise as lead compounds for MDR reversal.

Conclusions:

• Developing new drugs to inhibit MDR is crucial due to its increasing prevalence in cancer cells.
• Targeting ABC transporters offers a promising strategy to restore chemosensitivity.
• Further research into novel inhibitors and natural products can lead to improved cancer treatment outcomes.